logo
Plus   Neg
Share
Email

Ligand Pharmaceuticals Inc Q2 adjusted earnings Beat Estimates

Below are the earnings highlights for Ligand Pharmaceuticals Inc (LGND):

-Earnings: $22.09 million in Q2 vs. -$14.42 million in the same period last year.
-EPS: $1.32 in Q2 vs. -$0.74 in the same period last year.
-Excluding items, Ligand Pharmaceuticals Inc reported adjusted earnings of $16.66 million or $1.00 per share for the period.
-Analysts projected $0.76 per share
-Revenue: $41.42 million in Q2 vs. $24.99 million in the same period last year.

-Guidance:
Full year EPS guidance: $4.10
Full year revenue guidance: $165 Mln

For comments and feedback contact: editorial@rttnews.com

Follow RTT